Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ORTHOPEDIATRICS CORP.

(KIDS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OrthoPediatrics : SeaSpine Unit Enter Distribution Deal for 7D Flash Image Guidance System

09/10/2021 | 06:53am EDT


© MT Newswires 2021
All news about ORTHOPEDIATRICS CORP.
10/18ORTHOPEDIATRICS : Recognized in COVID Stops Here Campaign
AQ
10/13ORTHOPEDIATRICS : Expects Q3 Revenue to Rise 13% Sequentially; Reaffirms 2021 Guidance
MT
10/13ORTHOPEDIATRICS CORP : Results of Operations and Financial Condition, Financial Statements..
AQ
10/13ORTHOPEDIATRICS : Announces Preliminary Unaudited Revenue for the Third Quarter 2021 and R..
AQ
10/13OrthoPediatrics Corp. Provides Preliminary Revenue Guidance for the Third Quarter of 20..
CI
10/04ORTHOPEDIATRICS : Continues Support of Autumn Surgical Society Meetings
AQ
09/10ORTHOPEDIATRICS : SeaSpine Unit Enter Distribution Deal for 7D Flash Image Guidance System
MT
09/09SEASPINE : OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to ..
AQ
09/09OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusiv..
CI
08/12ORTHOPEDIATRICS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
More news
Analyst Recommendations on ORTHOPEDIATRICS CORP.
More recommendations
Financials (USD)
Sales 2021 98,4 M - -
Net income 2021 -27,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -45,2x
Yield 2021 -
Capitalization 1 274 M 1 274 M -
Capi. / Sales 2021 12,9x
Capi. / Sales 2022 10,7x
Nbr of Employees 116
Free-Float 69,9%
Chart ORTHOPEDIATRICS CORP.
Duration : Period :
OrthoPediatrics Corp. Technical Analysis Chart | KIDS | US68752L1008 | MarketScreener
Technical analysis trends ORTHOPEDIATRICS CORP.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 64,78 $
Average target price 77,40 $
Spread / Average Target 19,5%
EPS Revisions
Managers and Directors
David R. Bailey President & Chief Executive Officer
Fred L. Hite Director, Chief Operating & Financial Officer
Mark C. Throdahl Executive Chairman
Peter F. Armstrong Chief Medical Officer
Joel Batts Senior Vice President-Science & Technology
Sector and Competitors